Favorable outcome after adjuvant involved field radiotherapy post autologous hematopoietic stem cell transplantation in patients with high risk refractory/relapsed lymphoma: a single center experience.
Involved field radiotherapy has been used in the peri-transplant period to minimize the risk of disease recurrence after autologous stem cell transplantation in patients with bulky or residual lymphoma post-salvage chemotherapy. However, the optimal timing of radiotherapy still remains under investigation. We used involved field radiotherapy early post-transplant, in high risk patients, demonstrating high survival rates with extremely low toxicity.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Panayotis Kaloyannidis, Rawan Omari, Eman Eldebawy, Eshrak Al Shaibani, John Apostolidis, Taghreed Hindi, Heba Raslan, Ayed Al Garni, Ahmed Al Buali, Khalid Al Anezi, Hani Al Hashmi Tags: Original Study Source Type: research
More News: Chemotherapy | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants